<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-11012-2014082 - 2S2UI</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">HIV-patient organisations in action for affordable HIV treatment in Georgia, Kazakhstan and Moldova</narrative>
  </title>
  <description type="4">
   <narrative xml:lang="EN">Eastern Europe and Central Asia remains one of the most problematic regions in terms of HIV and HCV epidemic. According to the latest UNAIDS report, the HIV epidemic in the region continues to grow, and the HIV treatment coverage is approximately 25% of all the people in need of treatment. There is a growing need for more expensive 2nd and 3rd line antiretroviral drugs, as patient gradually become resistant to 1st line treatmen. When 2nd and 3rd line drugs are available, the prices for them are very high. The estimated number of people living with HCV in Moldova is 60,000 people. The estimated number of people living with HCV in Kazakhstan is 504,000 people; a rough estimate for Georgia is 200,000 people, though some sources give even higher figures.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">ITPCru is a regional organization operating in the Russian-speaking countries in Eastern Europe and Central Asia.This project will increase access to HIV/HCV treatment in this region through research and advocacy actions on intellectual property barriers. Community-based civil society groups in Georgia, Kazakhstan and Moldova will carry out research in the field of intellectual property barriers to second- and third-line antiretroviral medicines and direct-acting antiviral medicines for treating hepatitis C. An integral part of the research will be focused on how the following two methods for eliminating IP barriers &#x2013; patent opposition and compulsory licensing &#x2013; can be implemented given the specific country context.
Based on the results of the research, the communities will determine the drug(s) and the strategies which they will apply to increase access to the selected drug(s). The national organizations shall conduct practical advocacy steps to oppose patents and push their governments to issue compulsory licenses in a &#x201C;learning by doing&#x201D; mode. Over the project course, training and technical support in the field of IP will be provided. As a result, access to the selected drug(s) shall have been improved.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">Main outcomes:
# Increased capacity of the national patient communities in EECA in the field of IP and treatment access.
# IP barriers for access to treatment eliminated
# Increased awareness of the key decision-makers and the general public regarding IP and access to treatment.</narrative>
  </description>
  <description type="3">
   <narrative xml:lang="EN"></narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <participating-org role="4" type="23">
   <narrative xml:lang="EN">ITPC ru</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-12-31" type="1"></activity-date>
  <activity-date iso-date="2018-04-30" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <recipient-country code="GE" percentage="33.333333333333336"></recipient-country>
  <recipient-country code="KZ" percentage="33.333333333333336"></recipient-country>
  <recipient-country code="MD" percentage="33.333333333333336"></recipient-country>
  <sector code="15160" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">HIV-patient organisations in action for affordable HIV treatment in Georgia, Kazakhstan and Moldova Human rights</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2014-12-31"></period-start>
   <period-end iso-date="2018-04-30"></period-end>
   <value currency="EUR" value-date="2014-12-31">120000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">40000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSs 2014082</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">40000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSs 2014082</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-02-27"></transaction-date>
   <value currency="EUR" value-date="2016-02-27">14000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSs 2014082</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-02-27"></transaction-date>
   <value currency="EUR" value-date="2016-02-27">14000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSs 2014082</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-08-26"></transaction-date>
   <value currency="EUR" value-date="2016-08-26">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-08-27"></transaction-date>
   <value currency="EUR" value-date="2016-08-27">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-03-02"></transaction-date>
   <value currency="EUR" value-date="2017-03-02">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-03-03"></transaction-date>
   <value currency="EUR" value-date="2017-03-03">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-08-26"></transaction-date>
   <value currency="EUR" value-date="2017-08-26">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-08-27"></transaction-date>
   <value currency="EUR" value-date="2017-08-27">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-01-09"></transaction-date>
   <value currency="EUR" value-date="2018-01-09">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-01-09"></transaction-date>
   <value currency="EUR" value-date="2018-01-09">14000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">ITPC ru</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-12-31"></transaction-date>
   <value currency="EUR" value-date="2016-12-31">-11789</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">ITPC ru</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </receiver-org>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">A. The national patient community organizations in the project countries have gained considerable experience in the field of overcoming intellectual property barriers to increase treatment access</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Developing a questionnaire for experts in the field of IP and access to treatment</narrative>
   </description>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A1. Questionnaire</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="1"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A2. Interviews</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="15"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A5. Participants</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="15"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A3. Reports</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="3"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A4. Consultations</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="3"></target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">B. Improvements in terms of access to treatment to the selected drugs as a result of actions undertaken to revoke patents or issue compulsory licenses for the selected drugs</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Monitoring changes in the IP environment in the selected countries and issuing open letters, statements, position papers etc as a reaction to potential threats</narrative>
   </description>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">B4. Public events</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="13"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="12"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">B1. Patent interventions (search, oppositions, letters etc)</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="3"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">B2. Compulsory licensing  texts</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="3"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">B3. Public actions</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="3"></target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">C. The key government officials, other stakeholders and the general public and patient communities in EECA have been informed about the importance of the issue of eliminating intellectual property barriers to improve access to treatment</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Publicizing information about the project in the mass media, including mailing lists</narrative>
   </description>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">C4. Number of letters to the regional and international mailing lists</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="12"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="36"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">C2. Number of statements in favour of eliminating IP barriers made by decision-makers</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="8"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="36"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">C3. Number of press conferences, publications in the mass media</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="8"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="36"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">C1. Meetings with decision-makers</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="9"></actual>
    </period>
    <period>
     <period-start iso-date="2015-01-01"></period-start>
     <period-end iso-date="2018-05-01"></period-end>
     <target value="36"></target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
